MedPath

An Observational Study to Identify New Health Problems Arising After an Intensive Care Unit Admission in People With Acute Respiratory Distress Syndrome in the United States

Active, not recruiting
Conditions
Post Intensive Care Syndrome (PICS)
Acute Respiratory Distress Syndrome (ARDS)
Interventions
Other: An ICU admission and a temporally related ARDS diagnosis
Registration Number
NCT06272942
Lead Sponsor
Bayer
Brief Summary

This is an observational study in which data already collected from people with acute respiratory distress syndrome (ARDS) admitted to an intensive care unit (ICU) are studied.

ARDS is a life-threatening condition in which fluid builds up in the lungs making breathing difficult.

In observational studies, only observations are made without participants receiving any advice or any changes to health care.

People who are admitted to ICU for serious illnesses, like ARDS, often experience new health problems during and after their ICU stays. These health problems that may include physical, mental, and/or emotional disorders, are called post-intensive care syndrome (PICS). Identifying these new health problems early can help people by timely treatments and care.

In this study, researchers want to identify any health problems that arise after ICU admission in people with ARDS in the United States (US). To do this, researchers will collect information on health problems, treatments, medicines, and healthcare visits in people with ARDS, 1 year before and after an ICU admission.

They will then look to see whether the health problems are in areas that have been described as the post intensive care syndrome (PICS).

In addition, they will measure healthcare related costs in the one year after admission and compare it to the one year prior to admission.

Researchers will also compare this information with data collected for people with pneumonia who did not require ICU admission. This will help them to identify any new health problems arising due to ICU stays.

The data will come from participants' medical claims information stored in the Optum Clinformatics Data Mart database from 2016 to 2022. The claims data will only be collected for people in the US.

Researchers will collect data from participants admitted to ICU for ARDS for a maximum of 1 year before and after their stay.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
140000
Inclusion Criteria
  • continuous coverage of at least 365 days (>= 1 year) pre-index date for the cohort
  • age >= 18 years
  • not seen outside the healthcare system
Exclusion Criteria
  • none

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Post intensive care unit (ICU) morbidityAn ICU admission and a temporally related ARDS diagnosisAll adult patients in Optum Claims data from January 1, 2016 until October 1, 2022.
Primary Outcome Measures
NameTimeMethod
Morbidityat 1,3,6 and 12 month pre- and post- index hospital admission

Morbidity will be stratified by comorbidities, procedures, medications, healthcare utilization.

Difference in prevalence rates pre versus post index hospitalizationat 1, 3, 6 and 12 months post- index hospital admission
Average total healthcare costs based on healthcare billing data in the one year post index ICU admissionat 12 months post- index hospital admission

Average total healthcare costs will be based on healthcare billing data in the one year post index ICU admission.

Post ICU Syndrome-related morbidityat 12 months post- index hospital admission

PICS-related morbidity will be stratified by comorbidities, procedures, medications, healthcare utilization.

PICS stands for post intensive care unit syndrome.

Incident morbidityat 1, 3, 6 and 12 months post- index hospital admission

Incident morbidity will be stratified by comorbidities, procedures, medications, healthcare utilization.

Post ICU Syndrome-related incident morbidityat 1, 3, 6 and 12 months post- index hospital admission

PICS-related incident morbidity will be stratified by comorbidities, procedures, medications, healthcare utilization.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Bayer

🇺🇸

Whippany, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath